UROLOGIC NEOPLASMS
Clinical trials for UROLOGIC NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new UROLOGIC NEOPLASMS trials appear
Sign up with your email to follow new studies for UROLOGIC NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare kidney cancer: targeted drug savolitinib faces off against standard therapy
Disease control OngoingThis phase 3 study compares a new drug, savolitinib, to the standard drug sunitinib in 60 people with a specific type of advanced kidney cancer called MET-driven papillary renal cell carcinoma. The goal is to see if savolitinib is better at stopping the cancer from growing and to…
Matched conditions: UROLOGIC NEOPLASMS
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 23, 2026 11:58 UTC
-
New drug combo shows promise for Hard-to-Treat HER2 cancers
Disease control OngoingThis study tests a two-drug combination (tucatinib and trastuzumab) in people with advanced solid tumors that have HER2 alterations. The goal is to see if the treatment can shrink or control tumors. About 217 participants with various cancers (like lung, uterine, or bile duct) wi…
Matched conditions: UROLOGIC NEOPLASMS
Phase: PHASE2 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC